BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND HOXD11, ENSG00000128713, 3237
5 results:

  • 1. Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
    Sekine Y; Iwasaki Y; Aoi T; Endo M; Hirata M; Kamatani Y; Matsuda K; Sugano K; Yoshida T; Murakami Y; Fukui T; Akamatsu S; Ogawa O; Nakagawa H; Numakura K; Narita S; Habuchi T; Momozawa Y
    Hum Mol Genet; 2022 Jun; 31(12):1962-1969. PubMed ID: 35764097
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Trans-arterial embolization of renal cell carcinoma: a systematic review and meta-analysis.
    Wright B; Johnson BS; Vassar M; Saidian A; Rais-Bahrami S; Gunn AJ
    Abdom Radiol (NY); 2022 Jun; 47(6):2238-2243. PubMed ID: 35380246
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.
    Lin J; Yang T; Peng Z; Xiao H; Jiang N; Zhang L; Ca D; Wu P; Pan Q
    Cell Physiol Biochem; 2018; 48(1):397. PubMed ID: 30071532
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Economics of Palliative Care for Hospitalized Adults With Serious Illness: A Meta-analysis.
    May P; Normand C; Cassel JB; Del Fabbro E; Fine RL; Menz R; Morrison CA; Penrod JD; Robinson C; Morrison RS
    JAMA Intern Med; 2018 Jun; 178(6):820-829. PubMed ID: 29710177
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.
    Shimazui T; Oosterwijk E; Akaza H; Bringuier P; Ruijter E; van Berkel H; Wakka JO; van Bokhoven A; Debruyne FM; Schalken JA
    Clin Cancer Res; 1998 Oct; 4(10):2419-24. PubMed ID: 9796973
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.